Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 253
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT07219303 | Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer | ||
| NCT06416150 | Reducing Urban Cervical Cancer Disparities | ||
| NCT00761345 | Study of Low-Dose Fractionated Radiotherapy in Patients With Locally Advanced Metastatic Pancreatic Cancer | ||
| NCT07043972 | Gemcitabine and Carboplatin After Progression on Enfortumab Vedotin and Pembrolizumab in Advanced/Metastatic Urothelial Carcinoma | ||
| NCT06222242 | mychoiceTM Implementation With Medical Oncology Patients | ||
| NCT04506554 | A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer | ||
| NCT01183559 | A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery | ||
| NCT03427177 | Mychoice: Testing an Interactive mHealth Tool | ||
| NCT03094884 | Pulsed Low Dose Rate Radiation With Concurrent Chemotherapy for Non-Small Cell Lung Cancer and Esophageal Cancer | ||
| NCT02132858 | Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation | ||
| NCT05420636 | Iadademstat in Combination With Paclitaxel in Relapsed/Refractory SCLC and Extrapulmonary High Grade NET | ||
| NCT01726296 | Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care | ||
| NCT00694291 | Sorafenib in Hormone Naïve Biochemical Recurrence of Prostate Cancer | ||
| NCT00003264 | Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer | ||
| NCT01440855 | Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting | ||
| NCT07455032 | Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas | ||
| NCT00084591 | Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal Cancer | ||
| NCT04557423 | Evidence-Based Approach to Empower Asian American Women in Cervical Cancer Screening | ||
| NCT02966730 | Ibrutinib for Patients With Follicular Lymphoma Without Complete Response to Initial Chemoimmunotherapy | ||
| NCT00315185 | Study of Paclitaxel, Carboplatin, and Cetuximab for Advanced Lung Cancer | ||
| NCT05910190 | Buprenorphine for Cancer Pain | ||
| NCT05880667 | Adaptive Radiation for Abdominopelvic Metastases | ||
| NCT01934179 | Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy | ||
| NCT03172754 | Study of Nivolumab and Axitinib in Patients With Advanced Renal Cell Carcinoma | ||
| NCT02447887 | Study of Ixazomib With Pegylated IFN-alpha 2b (pIFN) in Metastatic Renal Cell Carcinoma (mRCC) | ||
| NCT00653146 | The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia | ||
| NCT01332279 | Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy | ||
| NCT06476938 | Testing Gene PilotLX With Latinx Cancer Patients | ||
| NCT04272619 | Liver Cancer Community Education | ||
| NCT01281514 | A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer | ||
| NCT00003109 | Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors | ||
| NCT00039507 | Radiofrequency Ablation During Surgery in Treating Patients With Non-Small Cell Lung Cancer | ||
| NCT03125928 | Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer | ||
| NCT00005848 | R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | ||
| NCT00483678 | Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners | ||
| NCT01937585 | Trial of Print Messages to Support the Role of Partners in Promoting Provider Discussions About Prostate Cancer Screening Among AA Men | ||
| NCT00700778 | Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations | ||
| NCT05360732 | Redefining FOLFIORINOX in Older Pancreatic Cancer Patients | ||
| NCT01739439 | Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery | ||
| NCT02211430 | Smoking Cessation for Low-Income Pregnant Women | ||
| NCT01285102 | Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer | ||
| NCT00043108 | Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer | ||
| NCT05263050 | Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors | ||
| NCT01121640 | A Trial Using Novel Markers to Predict Malignancy in Elevated-Risk Women | ||
| NCT00478309 | Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants | ||
| NCT00478452 | Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients | ||
| NCT05800587 | Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer | ||
| NCT00021333 | Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer | ||
| NCT00782834 | Nilotinib in Advanced Gastrointestinal Stromal Tumors (GIST) | ||
| NCT02609230 | A Dose-Escalation Study of Onc201 Administered Every One or Three Weeks in Advanced Solid Tumors and Multiple Myeloma |
